Skip to content
Search

Latest Stories

Submit Guest Post

ArcelorMittal may move thousands of Europe support roles to India

The plan could affect more than 5,600 support-function jobs in 20 countries across Europe, Jean-Luc Ruffin, secretary of the works council for the company’s staff in Europe said.

ArcelorMittal

The logo of ArcelorMittal at the entrance of their Dunkirk site in Grande-Synthe, northern France.

Getty Images

STEELMAKER ArcelorMittal is considering shifting thousands of support jobs from Europe to India, according to a senior employees' representative.

The plan could affect more than 5,600 support-function jobs in 20 countries across Europe, Jean-Luc Ruffin, secretary of the works council for the company’s staff in Europe, told AFP on Thursday.


ArcelorMittal Europe had already announced a first wave of relocations last year. Ruffin said that move affected around 4,000 jobs, including 1,400 job losses.

The works council said in a statement that the latest plan targets roles in areas such as IT, logistics and maintenance.

It described the move as an "attack on European workers... without consideration for the human, social and industrial consequences".

The council called for the new plans to be halted until last year’s relocations are completed and reviewed.

ArcelorMittal Europe said in a statement that it was "looking into the possibility of expanding the scope of its project to transform support functions, with the goal of ensuring optimisation and standardisation of activities which are currently fragmented across a large number of sites in Europe".

It added that "the creation of a business services hub in India and expanding the company's business centre of excellence in Poland will support in creating a sustainable business model for ArcelorMittal Europe".

(With inputs from agencies)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

AstraZeneca

AstraZeneca chief executive Pascal Soriot says the company has the science, pipeline and team to deliver its long-term growth ambitions

Getty Images

AstraZeneca targets $80bn revenue by 2030 with $1.5bn savings and pipeline investment

  • AstraZeneca expects its restructuring programme to generate $1.5bn in annualised savings by 2029, with most of the money reinvested in research and development.
  • The plan could incur up to $2bn in one-off restructuring costs, although the company expects its overall workforce to continue growing.
  • Third-quarter revenue rose 7 per cent to $16.21bn, while oncology sales increased 17 per cent to $7.77bn.

AstraZeneca has unveiled plans to generate around $1.5bn in annual savings through a three-year restructuring programme, as chief executive Pascal Soriot shifts the focus back to growth and investment in its drug pipeline.

The British-based pharmaceutical group said its Reshaping for Sustainable Growth programme would redirect resources towards research and development, particularly its pipeline of more than 180 projects and emerging technologies.

Keep ReadingShow less